¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"surface activity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mental activity
    Á¤½ÅȰµ¿
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
  • partial agonistic activity
    ºÎºÐÀÛ¿ëÁ¦È°¼º
  • specific activity
    1. ºñ¹æ»ç´É 2. ºñ(Ýï)Ȱ¼ºµµ, °íÀ¯È°¼ºµµ
  • spontaneous activity
    ÀÚ¹ßÀüÀ§
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • sexual activity
    ¼ºÈ°µ¿
  • approximal surface
    Á¢Ã˸é, ÀÎÁ¢¸é
  • articular surface
    °üÀý¸é
  • body surface mapping
    üǥ¸éÀüÀ§Áöµµ
  • cardiac surface map
    ½ÉÀåÇ¥¸éµµ
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • dorsal surface
    µîÂʸé, µÞ¸é, ¹èÃø¸é
  • fetal surface
    žÆ(ÂÊ)¸é
  • free surface
    ÀÚÀ¯¸é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molar activity
    ¸ôȰ¼º
  • partial agonistic activity
    ºÎºÐÈ¿´ÉȰ¼º
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
  • reflex gamma activity
    ¹Ý»ç°¨¸¶È°µ¿
  • sexual activity
    ¼ºÈ°µ¿
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • spontaneous activity
    ÀÚ¹ßÀüÀ§
  • time-activity curve
    ½Ã°£¹æ»ç´É°î¼±
  • professional activity study
    Àü¹®°¡È°µ¿¿¬±¸
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • sperm activity grade test
    Á¤Àڿµî±Þ°Ë»ç
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý¸é
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • plasma histaminase activity
    Ç÷ÀåÈ÷½ºÅ¸¹Ì³ª¾ÆÁ¦È°¼ºµµ.
  • plasma renin activity
    Ç÷Àå·¹´ÑȰ¼ºµµ<--Ȱµ¿µµ>
  • psychomotor activity
    Á¤½Å¿îµ¿¼º Ȱµ¿.
  • realtive sepcific activity
    »ó´ëºñ¹æ»ç´É
  • HBsAg => hepatitis B surface antigen
    B Çü °£¿° s Ç׿ø
  • Laibal surface
    ÀÔ¼ú¸é
  • anterior articular surface
    ¾Õ°üÀý¸é
  • anterior articular surface for talus
    ¾Õ¸ñ¸»°üÀý¸é
  • anterior calcaneal articular surface
    ¾Õ¹ß²ÞÄ¡°üÀý¸é
  • anterior surface
    ¾Õ¸é
  • anterior surface of eyelid
    ´«²¨Ç®¾Õ¸é
  • anterior surface of petrous portion
    ¹ÙÀ§¾Õ¸é
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • enzyme activity
    È¿¼ÒȰ¼º
  • enzyme activity
    È¿¼ÒȰ¼ºµµ
  • epidemiologic activity
    ¿ªÇÐÀû Ȱµ¿(ËçÌ°Ëø Ì·ËÄ).
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • fusion activity
    À¶ÇÕ´É
  • glucagon activity
    ±Û·çÄ«°ïȰ¼ºµµ.
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÀû ÇàÀ§
  • insulin like activity =ILa
    Àν¶¸°¾çȰ¼º(ÀÛ¿ë).
  • insulin-like activity substance
    Àν¶¸°¾çȰ¼º¹°Áú.
  • intrinsic activity
    ¾à¸®³»ÀÎ<Àç>¼º Ȱ¼º.
  • intrinsic activity
    ³»È°¼º(Ò®üÀàõ).[¾à¸®]³»ÀÎ<Àç>¼º Ȱ¼º.
  • intrinsic sympathomimetic activity
    ³»Àμº ±³°¨½Å°æÀ¯»çÀÛ¿ë.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Viceral surface
    ³»Àå¸é
    [¿¾ ¿ë¾î] ÀåÃø¸é
  • Visceral surface
    ³»Àå¸é
    [¿¾ ¿ë¾î] ÀåÃø¸é
  • Posterior surface of eyelids
    ´«²¨Ç®µÚ¸é
    [¿¾ ¿ë¾î] ¾È°ËÈĸé
  • Anterior surface of eyelid
    ´«²¨Ç®¾Õ¸é
    [¿¾ ¿ë¾î] ¾È°ËÀü¸é
  • Orbital surface
    ´«È®¸é
    [¿¾ ¿ë¾î] ¾È¿Í¸é
  • Cerebral surface
    ´ë³ú¸é
    [¿¾ ¿ë¾î] ´ë³ú¸é
  • Symphyseal surface
    µÎµ¢°áÇÕ¸é
    [¿¾ ¿ë¾î] Ä¡°ñ°áÇÕ¸é
  • Posterior articular surface
    µÚ°üÀý¸é
    [¿¾ ¿ë¾î] ÈİüÀý¸é
  • Dorsal surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Intestinal surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Posterior surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Posterior articular surface for talus
    µÚ¸ñ¸»°üÀý¸é
    [¿¾ ¿ë¾î] ÈİŰñ°üÀý¸é
  • Posterior calcaneal articular surface
    µÚ¹ß²ÞÄ¡°üÀý¸é
    [¿¾ ¿ë¾î] ÈÄÁ¾°ñ°üÀý¸é
  • Dorsal surface
    µî¸é
    [¿¾ ¿ë¾î] ¹èÃø¸é
  • Dorsal surface
    µîÂʸé
    [¿¾ ¿ë¾î] ¹èÃø¸é
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼º (üÀàõ)
  • activity coefficient
    Ȱ·®°è¼ö (üÀÕá°èâ¦)
  • catalytic center activity
    Ã˸ÅÁß½É È°¼º(õºØÚñéãýüÀàõ)
  • concentration of enzymatic activity
    È¿¼ÒȰ¼º ³óµµ(ý£áÈüÀàõÒØÓø)
  • enzymatic activity
    È¿¼Ò Ȱ¼º (ý£áÈüÀàõ)
  • intrinsic activity
    ³»ÀçȰ¼º(Ò®î¤üÀàõ)
  • mean activity coefficient
    Æò±ÕȰµ¿°è¼ö(øÁгüÀÔÑͪâ¦)
  • mean ionic activity coefficient
    Æò±Õ(øÁг) ÀÌ¿ÂȰ¼º°è¼ö(üÀàõͪâ¦)
  • molar activity
    ¸ô Ȱ¼º(üÀàõ)
  • molecular activity
    ºÐÀÚȰ¼º(ÝÂí­üÀàõ)
  • myotropic activity
    ±Ù°­È­È°¼º(ÐÉË­ûùüÀàõ)
  • optical activity
    ±¤ÇРȰ¼º(ÎÃùÊüÀàõ)
  • Raman optical activity
    ¶ó¸¸ ±¤ÇРȰ¼º(µµ)(ÎÃùÊüÀàõ(Óø))
  • relative specific activity
    »ó´ë ƯÀÌ È°¼ºµµ(ßÓÓß÷åì¶üÀàõÓø)
  • specific activity
    ºñȰ¼º(ÝïüÀàõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ventromedial surface
    ³»ÃøÀü¸é, º¹³»Ãø
  • wound surface
    â¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSA Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen...
SAS sarcoma amplified sequence; self-rating anxiety scale; short arm splint; Sklar Aphasia Scale; sleep ...
SSA salicylsalicylic acid; sicca syndrome A; skin-sensitizing antibody; skin sympathetic activity; Sjogr...
CIA chemiluminescent immunoassay; chymotrypsin inhibitor activity; colony-inhibiting activity; congenita...
ECA electrical control activity; electrocardioanalyzer; endothelial cytotoxic activity; enterobacterial ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSH Cell surface hydrophobicity
ESD Entrance surface dose
HBs Ag HB surface antigen
HSM Heparin surface modified
HBsAg hepatitis B surface ant,gen
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intrinsic sympathomimetic activity
    ³»Àμº ±³°¨½Å°æ À¯»ç ÀÛ¿ë
  • lip activity
    ÀÔ¼ú ¿îµ¿, ÀÔ¼ú Ȱµ¿·Â
  • maintained activity
    Ȱ¼º À¯Áö
  • mental activity
    Á¤½Å Ȱµ¿
  • molar activity
    ¸ô Ȱ¼º
  • muscle activity
    ±Ù Ȱ¼º
  • muscular activity
    ±ÙÀ° Ȱµ¿, ±Ù Ȱ¼ºµµ
  • neuromuscular reflex activity
    ±Ù½Å°æ ¹Ý»ç Ȱµ¿
  • nociceptor activity
    Ä§ÇØ ¼ö¿ëü Ȱ¼º, À¯ÇØ ¼ö¿ë±â Ȱ¼º
  • partial agonistic activity
    ºÎºÐ È¿´É, ºÎºÐ È¿´ÉÀû Ȱ¼º, ºÎºÐ È¿ÇöÀû Ȱ¼º
  • persistent activity
    Áö¼ÓÀûÀΠȰ¼º
  • phagocytic activity
    ½Ä¼¼Æ÷´É
  • play activity
    ³îÀÌ
  • postural electromyographic activity
    ÀÚ¼¼¼º ±ÙÀüµµ Ȱ¼º
  • reflex activity
    ¹Ý»ç Ȱµ¿
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
nonsuppressible insulin-like activity A blood protein (nsila) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of cohn fraction III, 10% of the activity is found in the supernatant (nsila-s) and the remaining activity in the precipitate (nsila-p). The latter is a large molecular compound, much less stable than the soluble fraction. Nsila-s is a more potent growth factor than insulin and exhibits sulfation activity.
(12 Dec 1998)
drug activity A measure of the physiological response a drug produces. A less active drug produces less response (and visa versa).
(12 Dec 1998)
insulin-like activity A measure of substances, usually in plasma, that exert biologic effects similar to those of insulin in various bioassays; sometimes used as a measure of plasma insulin concentrations; always gives higher values than immunochemical techniques for the measurement of insulin.
(05 Mar 2000)
intrinsic sympathomimetic activity The property of a drug that causes activation of adrenergic receptors so as to produce effects similar to stimulation of the sympathetic nervous system.
(05 Mar 2000)
optical activity The ability of a material to rotate the plane of polarized light.
(09 Oct 1997)
triggered activity One or a series of spontaneously generated heart beats originating from an action potential that produces an after-depolarisation which reaches activation threshold.
(05 Mar 2000)
unit of thyrotrophic activity The activity of an amount of an extract of the anterior lobe of the hypophysis which, given daily for 5 days, will cause the thyroid of a guinea pig (weighing 200 g) to reach a weight of 600 mg.
(05 Mar 2000)
zone of polarizing activity <cell biology> The small group of mesenchyme cells in avian limb buds that is located at the posterior margin of the developing bud and that produces a substance, possibly retinoic acid, that provides positional information to the developing limb bud.
(18 Nov 1997)
acromial articular surface of clavicle A small oval facet on the lateral end of the clavicle for articulation with the acromion.
Synonym: facies articularis acromialis claviculae, acromial articular facies of clavicle.
(05 Mar 2000)
anterior part of diaphragmatic surface of liver The part of the diaphragmatic surface of the liver deep to the costal arches and the xiphoid process.
Synonym: pars anterior faciei diaphragmatis hepatis.
(05 Mar 2000)
anterior surface The surface of a structure or part of the body that faces forward.
Synonym: facies anterior.
(05 Mar 2000)
anterior surface of arm Anterior articular surface of dens, the curved articular facet on the anterior aspect of the dens of the axis that articulates with the facet for the dens of the axis anterior arch of the atlas.
Synonym: facies articularis anterior dentis.
(05 Mar 2000)
anterior surface of cornea The external surface of the cornea.
Synonym: facies anterior corneae.
(05 Mar 2000)
anterior surface of elbow The area in front of the elbow, including the cubital fossa.
Synonym: facies cubitalis anterior, regio cubitalis anterior, anterior cubital region, anterior surface of elbow.
(05 Mar 2000)
anterior surface of eyelids anterior surface of eyelids
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • surface water
    ÁöÇ¥¼ö(ÁöÇϼö¿¡ ´ëÇØ);Ç¥¸é ¼ö·®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á